Laura Moore, M.Ed., R.D., L.D., and her husband Don Sanders have donated $1 million to support a first-of-its-kind nutrition education program at The University of Texas Health Science Center at Houston (UTHealth). UTHealth fully matched the gift as part of the university’s Game Changers Initiative.
The immunotherapy drug nivolumab in combination with standard chemotherapy more than doubled response rates and improved overall survival in patients with acute myeloid leukemia (AML), according to preliminary findings by researchers at The University of Texas MD Anderson Cancer Center.
Richard Gorlick, M.D., an internationally recognized expert in pediatric oncology and hematology, today joined The University of Texas MD Anderson Children’s Cancer Hospital as the division head and department chair of Pediatrics.
Patients who potentially could benefit most from participation in clinical trials due to poor prognoses often are not included based on eligibility criteria, such as existing medical illnesses.
Patients successfully treated for breast, colon and other cancers can go on to develop an often-fatal form of leukemia, sometimes years after completion of treatment, due to a genetic mutation leading to secondary malignancies known as therapy-related myeloid neoplasms (t-MNs).
The Houston Methodist Research Institute’s department of nanomedicine is the recipient of this year’s AIDS Foundation Houston Shelby Hodge Vision Award. Alessandro Grattoni, Ph.D., nanomedicine department chair at the Houston Methodist Research Institute, accepted the award during the World AIDS Day luncheon.
Carlos Moreno, M.D., chairman of the Department of Family and Community Medicine at McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth), has been recognized for his contributions to community health by Spring Branch Community Health Center (SBCHC).
Dealing with Alzheimer’s disease can be difficult any time of year, but the holidays present unique challenges for patients and their families.
A cellular component known as the Golgi apparatus may play a role in how lung cancer metastasizes, according to researchers at The University of Texas MD Anderson Cancer Center whose findings were reported in the Nov. 21 online issue of the Journal of Clinical Investigation.
The holiday season sometimes brings with it excessive alcohol consumption. Women need to be aware that even a lit bit of holiday cheer can cause some serious health problems.
In recognition of wide-ranging contributions to the fields of cancer prevention, patient care, and basic, translational, and clinical research, seven faculty members from The University of Texas MD Anderson Cancer Center have been named Fellows of the American Association for the Advancement of Science (AAAS).
Study Highlights • Designed a smart drug that only targets and kills GBM brain cancer cells. • Validated a compound that sensitizes GBM tumors to chemotherapy and results in a significant extension of life in an animal model.
Glioblastoma multiforme remains the most common and highly lethal brain cancer and is known for its ability to relapse.
UTHealth and Purdue Pharma L.P. have entered into a specialized alliance to bring academic researchers and drug developers closer together with the common goals of accelerating the development of new drug therapies for patients while advancing the science and providing unique educational experiences for both.
Calorie-laden meals, decadent treats, and festive drinks inundate people from Thanksgiving to New Year’s Day, inviting the fiery sensation of heartburn and bitter taste of reflux as unwelcome guests to the holiday festivities.
For people living with sickle cell disease, chronic pain becomes an all too familiar part of everyday life. The UT Physicians Comprehensive Sickle Cell Center is working to help change that.
Astronauts survive in space by wearing high-tech space suits. But how do brain cancer cells thrive when they migrate to inhospitable sites within the brain?
Millions of people will be traveling next week for Thanksgiving. Deep vein thrombosis can fatal for travelers if they sit for too long on a plane or in a car.
Research published by a Houston Methodist team led by John Cooke, M.D., Ph.D., received high accolades at this year’s American Heart Association Scientific Sessions.
The holiday season is officially in full gear and with it comes the tempting Thanksgiving-to-New-Year’s food fest. During the holiday season, good eating habits spiral out of control and exercise plans are thrown out the window resulting in undesired weight gain.
When female employees of a mystery shopping firm called posing as 17-year-olds interested in tanning, 81 percent of indoor tanning facilities complied with the Texas ban on indoor tanning for those under the age of 18 in a study conducted by The University of Texas MD Anderson Cancer Center.
The Houston Texans and GE are collaborating with the Houston Methodist Concussion Center to fund a two-year pilot project to bring specialized concussion care via telemedicine to athletes in rural areas.
click to view recent experts and research related to the 2016 Election
Houston Methodist researchers have discovered a set of immune proteins that facilitate long-lasting immunity against malaria. In a study recently published in Immunity (online Oct. 25), researchers reported that elevated production of specific proteins regulating the immune system within 24 hours of infection was required for a resilient and sustained anti-malaria immunity in mice.
Since 1941, when the Texas Legislature established the state’s first cancer hospital, The University of Texas MD Anderson Cancer Center has been a beacon of hope for more than 1.1 million patients.
Results of a cellular therapy clinical trial for traumatic brain injury (TBI) using a patient’s own stem cells showed that the therapy appears to dampen the body’s neuroinflammatory response to trauma and preserve brain tissue, according to researchers at The University of Texas Health Science Center at Houston (UTHealth).
Researchers at The University of Texas MD Anderson Cancer Center have developed a new personalized assessment tool that could better predict lung cancer risk in never, light and heavy smokers using a large Taiwanese prospective cohort study.
High out-of-pocket costs, rather than race or ethnicity, are responsible for disparities associated with adherence to adjuvant endocrine therapy, according to a new study from researchers at The University of Texas Health Science Center at Houston (UTHealth) School of Public Health.
Maria E. Fernandez, Ph.D., professor and director of the Center for Health Promotion and Prevention Research at The University of Texas Health Science Center at Houston (UTHealth) School of Public Health, recently received the Distinguished Alumni Award from her alma mater, the University of Maryland School of Public Health.
To help doctors address the obesity epidemic, McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth) now offers a fellowship in obesity medicine.
The University of Texas MD Anderson Cancer Center’s Institute for Applied Cancer Science (IACS) has initiated the first clinical study of a novel drug designed to starve cancer cells, IACS-10759.
Tonya Edwards, a clinical nurse in Palliative Care at The University of Texas MD Anderson Cancer Center, is the recipient of the 2016 Brown Foundation Award for Excellence in Oncology Nursing.
HOUSTON–(Oct. 19, 2016)–Researchers at Houston Methodist kept mice from getting the flu by removing a gene that regulates their immune system. According to a study recently published in Nature Immunology (online Oct. 3), mice missing the gene Trim29 eliminated human influenza virus within 48 hours, protecting them from infection.
As football and soccer become year-round sports, their popularity accounts for more concussions and head injuries. This has parents, athletes and head injury experts at Harris Health System sounding the alarm of long-term health concerns for concussed participants.
The role of child life specialists is traditionally one of helping hospitalized children cope with their illness, treatment and hospital stay. However, at Harris Health System, child life is breaking with tradition to help patients suffering severe illnesses talk to their children about their medical condition in life and death terms.
Fifteen percent of sixth-grade students reported they had perpetrated at least one form of abuse toward a dating partner through technology, according to a new study from The University of Texas Health Science Center at Houston (UTHealth) School of Public Health.
Children who suffer head injuries from falls or sports can usually recover quickly. However, this recovery trait is not always there, say Harris Health System experts. They warn these injuries can lead to significant life-changing physical, emotional or cognitive development.
The University of Texas MD Anderson Cancer Center and the Houston Independent School District (HISD) have reached a first-of-its-kind agreement to provide access to an evidence-based, youth-oriented tobacco prevention and cessation program for all 110,000 HISD middle and high school students.
HOUSTON-(Oct. 11, 2016)–Scientists at Houston Methodist received support from the U.S. Department of Defense (DoD) to reprogram immune cells to attack triple negative breast cancer, the most lethal form of the disease. The DoD awarded Rongfu Wang, Ph.D., director of the Center for Inflammation & Epigenetics at Houston Methodist Research Institute, $3 million to create a personalized vaccine that retrains cancer patients’ immune systems to safely target and eliminate breast tumors and spare normal tissue.
In a randomized, Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, ribociclib, in combination with the aromatase inhibitor letrozole, dramatically improved progression-free survival (PFS) of post-menopausal women with hormone receptor-positive metastatic breast cancer, compared to the hormone therapy alone.
With violent images and breaking news of shootings and killings constantly on television, how do parents navigate these images to protect their children from negative effects. That all depends on the child's age and mental state, says a Harris Health System psychiatrist.
All 13 newly diagnosed breast cancer patients with BRCA mutations had their tumors shrink significantly when treated with a PARP inhibitor ahead of frontline presurgical chemotherapy in a pilot study at The University of Texas MD Anderson Cancer Center.
Houston Methodist received $9 million from the National Cancer Institute to establish the Center for Immunotherapeutic Transport Oncophysics (CITO). CITO combines the studies of cancer immunology, nanotechnology and the physics of cancer biology. CITO will focus on using research information to design immunotherapies for breast and pancreatic cancers.
Jair C. Soares, M.D., Ph.D., chair of McGovern Medical School Department of Psychiatry and Behavioral Sciences and Pat R. Rutherford Chair in Psychiatry, has been named a 2016 Chancellor’s Health Fellow for The University of Texas System Office of Health Affairs.
The Trauma and Grief (TAG) Center for Youth at UTHealth will expand screening, assessment and intervention for traumatized and bereaved youth into the Houston Independent School District (HISD). The program is funded in part by The Brown Foundation, Inc.
A safe, noninvasive weak electrical current delivery called transcranial direct current stimulation (tDCS) will be investigated for its potential in treating schizophrenia patients in a study led by Raymond Cho, M.D., M.Sc., at McGovern Medical School at UTHealth.
Angela House, in collaboration with The University of Texas Health Science Center at Houston (UTHealth) and Healthcare for the Homeless – Houston (HHH), has received a grant from the Robert Wood Johnson Foundation to evaluate a holistic health care program for formerly incarcerated women.
Run Wang, M.D., professor and Cecil M. Crigler, M.D. Chair in Urology at McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth), has been elected to a two-year term as president of the Sexual Medicine Society of North America.
In a review of guideline-concordant treatment modalities for women with early stage breast cancer, mastectomy and reconstruction had the highest rate of complications and complication-related costs, regardless of age.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right